Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07191561 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hepatic Lipid Metabolism-Alcohol Use Disorder

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 194 record versions are listed below. See every version on ClinicalTrials.gov ↗

  1. Minor Start date changed from estimate of Oct 12, 2026 to Oct 5, 2026
  2. Minor Start date: Oct 11, 2026 to Oct 12, 2026
  3. Minor Start date: Oct 8, 2026 to Oct 11, 2026
  4. Minor Start date: Oct 7, 2026 to Oct 8, 2026
  5. Minor Start date: Oct 6, 2026 to Oct 7, 2026
Show 45 earlier versionsHide 45 earlier versions
  1. Minor Start date: Oct 5, 2026 to Oct 6, 2026
  2. Minor Start date: Oct 4, 2026 to Oct 5, 2026
  3. Minor Start date: Sep 20, 2026 to Oct 4, 2026
  4. Minor Start date: Sep 17, 2026 to Sep 20, 2026v186
  5. Minor Start date: Sep 16, 2026 to Sep 17, 2026v185
  6. Minor Start date: Sep 15, 2026 to Sep 16, 2026v184
  7. Minor Start date: Sep 14, 2026 to Sep 15, 2026v183
  8. Minor Start date: Sep 10, 2026 to Sep 14, 2026v182
  9. Minor Start date: Sep 9, 2026 to Sep 10, 2026v181
  10. Minor Start date: Sep 8, 2026 to Sep 9, 2026v180
  11. Minor Start date: Sep 7, 2026 to Sep 8, 2026v179
  12. Minor Start date: Sep 6, 2026 to Sep 7, 2026v178
  13. Minor Start date: Sep 3, 2026 to Sep 6, 2026v177
  14. Minor Start date: Sep 2, 2026 to Sep 3, 2026v176
  15. Minor Start date: Sep 1, 2026 to Sep 2, 2026v175
  16. Minor Start date: Aug 31, 2026 to Sep 1, 2026v174
  17. Minor Start date: Aug 30, 2026 to Aug 31, 2026v173
  18. Minor Start date: Aug 27, 2026 to Aug 30, 2026v172
  19. Minor Start date: Aug 26, 2026 to Aug 27, 2026v171
  20. Minor Start date: Aug 25, 2026 to Aug 26, 2026v170
  21. Minor Start date: Aug 24, 2026 to Aug 25, 2026v169
  22. Minor Start date: Aug 23, 2026 to Aug 24, 2026v168
  23. Minor Start date: Aug 20, 2026 to Aug 23, 2026v167
  24. Minor Start date: Aug 19, 2026 to Aug 20, 2026v166
  25. Minor Start date: Aug 18, 2026 to Aug 19, 2026v165
  26. Minor Start date: Aug 17, 2026 to Aug 18, 2026v164
  27. Minor Start date: Aug 16, 2026 to Aug 17, 2026v163
  28. Minor Start date: Aug 13, 2026 to Aug 16, 2026v162
  29. Minor Start date: Aug 12, 2026 to Aug 13, 2026v161
  30. Minor Start date: Aug 11, 2026 to Aug 12, 2026v160
  31. Minor Start date: Aug 10, 2026 to Aug 11, 2026v159
  32. Minor Start date: Aug 7, 2026 to Aug 10, 2026v158
  33. Minor Start date: Aug 6, 2026 to Aug 7, 2026v157
  34. Minor Start date: Aug 5, 2026 to Aug 6, 2026v156
  35. Minor Start date: Aug 4, 2026 to Aug 5, 2026v155
  36. Minor Start date: Aug 3, 2026 to Aug 4, 2026v154
  37. Minor Start date: Aug 2, 2026 to Aug 3, 2026v153
  38. Minor Start date: Jul 30, 2026 to Aug 2, 2026v152
  39. Minor Start date: Jul 29, 2026 to Jul 30, 2026v151
  40. Minor Start date: Jul 28, 2026 to Jul 29, 2026v150
  41. Minor Start date: Jul 27, 2026 to Jul 28, 2026v149
  42. Minor Start date: Jul 26, 2026 to Jul 27, 2026v148
  43. Minor Start date: Jul 23, 2026 to Jul 26, 2026v147
  44. Minor Start date: Jul 22, 2026 to Jul 23, 2026v146
  45. Minor Start date: Jul 21, 2026 to Jul 22, 2026v145
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Patients with hepatic steatosis due to alcohol will be offered liver biopsies when they enter a detoxification program. The first biopsy will occur in the first week of admission and the second in the fourth week when the steatosis has resolved. The hepatic transcriptome will be compared,
Trial Details
NCT Number NCT07191561
Lead Sponsor National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Alcohol Use Disorder
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov